Danilo Wegner
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in ⓘ
-
- Gastroesophageal reflux and treatments 4
- Gastrointestinal motility and disorders 2
-
- Pharmacogenetics and Drug Metabolism 4
- Antibiotics Pharmacokinetics and Efficacy 4
- Drug-Induced Hepatotoxicity and Protection 2
- Co-authors
- Werner Siegmund (14 shared papers)Christiane Modeß (9 shared papers)Thomas Gießmann (6 shared papers)Stefan Oswald (8 shared papers)M Zschiesche (2 shared papers)Werner Weitschies (6 shared papers)Ingolf Cascorbi (3 shared papers)R Warzok (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (5 papers)Clinical Pharmacology & Therapeutics (2 papers)Pharmaceutical Research (1 paper)mAbs (1 paper)Molecular Pharmaceutics (1 paper)
- Partner nations
- GermanySouth KoreaUnited States
In The Last Decade
Danilo Wegner
19 papers receiving 568 citations
Peers
Comparison fields: 5 of 81
- Pharmacology 123
- Oncology 328
- Pediatrics, Perinatology and Child Health 198
- Pharmaceutical Science 37
- Infectious Diseases 91
Countries citing papers authored by Danilo Wegner
This map shows the geographic impact of Danilo Wegner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danilo Wegner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danilo Wegner more than expected).
Fields of papers citing papers by Danilo Wegner
This network shows the impact of papers produced by Danilo Wegner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danilo Wegner. The network helps show where Danilo Wegner may publish in the future.
Co-authors
The 25 scholars most cited alongside Danilo Wegner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 146 | |
| 2 | 2008 | 73 | |
| 3 | 2014 | 59 | |
| 4 | 2005 | 56 | |
| 5 | 2016 | 44 | |
| 6 | 2006 | 37 | |
| 7 | 2006 | 35 | |
| 8 | 2019 | 27 | |
| 9 | 2017 | 25 | |
| 10 | 2015 | 15 | |
| 11 | 2008 | 13 | |
| 12 | 2008 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2019 | 10 | |
| 15 | 2017 | 7 | |
| 16 | 2019 | 6 | |
| 17 | 2012 | 3 | |
| 18 | 2017 | 2 | |
| 19 | [Secretin-pancreozymin test with volume correction in the functional diagnosis of pancreatobiliary secretion]. | 1987 | 1 |
About Danilo Wegner
Danilo Wegner is a scholar working on Gastroenterology, Pharmacology, Oncology, Pediatrics, Perinatology and Child Health and Pharmacology, having authored 19 papers that have together received 582 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Pharmacological Effects and Toxicity Studies (5 papers), Pharmacogenetics and Drug Metabolism (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Gastroesophageal reflux and treatments (4 papers), Gastrointestinal motility and disorders (2 papers), Sphingolipid Metabolism and Signaling (2 papers) and Drug-Induced Hepatotoxicity and Protection (2 papers). The work is most often cited by research in Pharmacology (123 citations), Oncology (328 citations), Pediatrics, Perinatology and Child Health (198 citations), Pharmaceutical Science (37 citations) and Infectious Diseases (91 citations). Danilo Wegner has collaborated with scholars based in Germany, South Korea and United States. Frequent co-authors include Werner Siegmund, Christiane Modeß, Thomas Gießmann, Stefan Oswald, M Zschiesche, Werner Weitschies, Ingolf Cascorbi, R Warzok, Sierk Haenisch and K. May. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Pharmaceutical Research, mAbs and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.